Author

Camille Jouines

Lyon 1 Université

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Research Focus:perturbation response prediction· 1

Frequent Co-Authors

Angéline Gaucherot· 2 shared Frédéric CateziD· 2 shared Jean‐Jacques DiaziD· 2 shared Marie‐Ambre MonetiD· 2 shared Piero Lo MonacoiD· 2 shared Virginie MarceliD· 2 shared Carine FromentiD· 1 shared Caroline IsaaciD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Angéline Gaucherot

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Fibrillarin-mediated ribosomal RNA maturation is a novel therapeutic vulnerability in triple-negative breast cancer

Camille Jouines, Piero Lo Monaco, Angéline Gaucherot, Julie Radermecker, Caroline Isaac, Fleur Bourdelais, Marie‐Ambre Monet, Marion Meyer, Mounira Chalabi‐Dchar, Flora Nguyen Van Long, Laury Baillon, Carine Froment, Julien Marcoux, Christophe Vanbelle, Tanguy Fenouil, , Frédéric Catez

This study identifies ribosome biogenesis as a therapeutic vulnerability in TNBC, showing that inhibiting rRNA maturation via Fibrillarin or RNA Pol I reduces tumor growth without significant cell death.

Breast Cancer Research · Nov 13, 2025Peer-reviewedCancer Biology

Ribosome biogenesis is a therapeutic vulnerability in paediatric neuroblastoma

Camille Jouines, Piero Lo Monaco, Angéline Gaucherot, Marie‐Ambre Monet, Isabelle Iacono, Valentin Simioni, Déborah Monchiet, Jean‐Jacques Diaz, Valérie Combaret, Virginie Marcel, Frédéric Catez

This study investigates ribosome biogenesis as a therapeutic target in neuroblastoma, showing that inhibiting RNA polymerase I reduces cell proliferation and induces apoptosis.

bioRxiv · Mar 26, 2025 · PreprintCancer Biology